Stay updated on HMPL-689 Safety & PK in Lymphomas Clinical Trial
Sign up to get notified when there's something new on the HMPL-689 Safety & PK in Lymphomas Clinical Trial page.

Latest updates to the HMPL-689 Safety & PK in Lymphomas Clinical Trial page
- Check4 days agoChange DetectedA new consolidated Locations section is added with multiple sites (California, Georgia, New York, North Carolina, Texas, Washington, and Val de Marne in France) and the revision updated to v3.3.3, replacing the prior site-specific listings.SummaryDifference0.7%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2; no substantive changes to study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check40 days agoChange DetectedRemoved the government funding/operating status notice from the page, removing guidance about NIH/OPM updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check62 days agoChange DetectedResults for the study have been posted (Results First Posted 2025-06-26) and the study record dates and QC status have been updated to reflect the new information.SummaryDifference0.4%

- Check85 days agoChange DetectedAdded a government-operating-status notice and a new version tag (v3.2.0); removed the previous version tag (v3.1.0).SummaryDifference2%

- Check92 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. The core page content shifts to the newer release identifier; no other substantive content changes are indicated.SummaryDifference0.1%

Stay in the know with updates to HMPL-689 Safety & PK in Lymphomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HMPL-689 Safety & PK in Lymphomas Clinical Trial page.